Thank you, Matthew, and thank you to everyone joining us here today. Before I begin, I’d like to note that our financial results on Form 10-Q were filed with the SEC on August 15. With that, I would like to give an overview of the financials for the second quarter of 2022. The company recognized no revenues during the three months ended June 30, 2022, and no revenues for the same period in 2021. Our net cash used in operations for the quarter ended June 30, 2022, was approximately $1.8 million, compared to approximately $2.2 million for the same period in 2021. For the six months ended on June 30, our net losses decreased approximately $1.2 million compared to the same period in 2021. The decrease in net loss is primarily attributable to decreased research and development costs. Research and development costs have decreased due to lower human capital costs and lower product development costs. Product development costs have decreased year-over-year mainly due to the change in focus of our engineers. The change in focus is to support sales initiatives and to provide customer technical support. As previously reported, on June 1, we closed an underwritten public offering of 4,186,000 shares of our common stock at a price to the public of $1.11 per share. As a result of this offering, net cash proceeds to ClearSign were approximately $4.2 million. As a result of the aforementioned underwritten public offering completed on June 1, 2022, and pursuant to the purchase right, clirSPV LLC purchased its entire allotment of 1,591,594 shares at a price of $1.11 per share. This resulted in net cash proceeds to ClearSign of approximately $1.7 million. Please note the purchase right was exercised after June 30, 2022, and thus, the effects of this transaction were not reported on the face of the financials but rather disclosed within our subsequent events footnote. The purchase right granted to clirSPV LLC comes from the original stock purchase agreement dated July 12, 2018, between the company and clirSPV LLC. The purchase right states that clirSPV members can participate in certain future equity offerings if they choose to do so by purchasing enough unregistered shares to allow the SPV to maintain their 19.99% ownership of the company’s outstanding common stock. As of August 1, 2022, there were 37,951,559 shares of our common stock issued and outstanding. The cash balance as of June 30, 2022, was approximately $9.7 million, which does not reflect the aforementioned SPV investment. We have confidence in our financial position and balance sheet. And with our quarter ended balances, we have sufficient working capital available to carry us through 2024. And that is without cash from any other sources. Just to note from a cash perspective and subsequent to June 30, we have received payment from outstanding invoices from multiple process burner projects. And with that, I would like to turn the call over to our CEO, Jim Deller. Jim?